Research & Development
Media & Press
Point-of-Care Testing: Page 2
Virax introduces rapid test kit for RSV, influenza A/B, COVID-19
Virax Biolabs announced the distribution of a rapid antigen test kit capable of detecting when individuals have been infected with RSV, Influenza A/B, or COVID-19.
November 3, 2022
FDA clears Baebies disposable G6PD test
The rapid point-of-care test uses a drop of blood to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency, which causes hemolytic anemia.
November 9, 2022
Osler Diagnostics raises $85M in Series C financing
Osler Diagnostics said that the Series C financing will support its portable testing platform, which aims to provide a broad menu of tests.
November 7, 2022
Sense Biodetection signs distribution agreement with Biotecom for MDx platform
The agreement allows Biotecom to provide Chilean hospitals, laboratories, and clinics with the Veros molecular testing platform.
November 2, 2022
QuantuMDx inks distribution agreement with Menarini
According to the agreement, Menarini will handle the distribution and marketing of the Q-POC platform, COVID assay, and QuantuMDx’s SARS-CoV-2/Flu A/B/RSV Respiratory Panel test in the U.K. and France.
November 2, 2022
QMC Health, Lawson Health Research ink agreement for long-COVID blood biomarkers
With blood biomarkers acquired in an agreement with Lawson Health Research Institute, QMC Health plans to develop a point-of-care rapid test using its QDX HPFIS technology.
November 1, 2022
Dr. Fauci invokes Yogi Berra to describe emerging infectious disease challenge
C2N Diagnostics launching next-generation blood test for Alzheimer's disease detection
Thermo Fisher Scientific introduces digital PCR liquid-biopsy assays for academic, clinical research
Thermo Fisher Scientific updates Applied Biosystems genetic analyzers to comply with IVDR
Aspira announces commercial launch of blood-based ovarian cancer risk assay
Sherlock Biosciences secures funding to further develop CRISPR testing platform
Nanomix signs distribution agreement with Mast Group for immunoassay and chemistry diagnostic system
Nanomix has signed an agreement with Mast Group, allowing the company to distribute Nanomix’s eLab system to the U.K., France, Germany, Ireland, and South Africa.
November 4, 2022
BMJ investigation: Private testing causing concerns and additional work for NHS
Ambiguity about test results, lack of counseling, and blanket recommendations to see one’s doctor following abnormal test results put further strain on providers in the already-overtaxed NHS, the BMJ article asserts.
October 27, 2022
Researchers developing probe to rapidly detect gum disease
Researchers from the University of Birmingham in the U.K. are developing a dental probe, which is believed to be the first of its kind, that can quickly identify periodontal disease and its severity from a saliva sample.
October 26, 2022
University of Illinois spinout Shield T3 launches saliva-based PCR test for COVID, flu, RSV
Shield T3, a spinout of the University of Illinois, will offer a triple-virus PCR test kit, in anticipation of increased cases of COVID-19, flu, and RSV this winter.
October 25, 2022
UCLA research shows rapid antigen tests may be effective tools for return-to-work programs
Researchers from UCLA conducted a study examining how antigen test results may be used to guide healthcare systems implementing return-to-work protocols.
October 24, 2022
Walgreens Flu Index shows 2022-2023 season exhibiting tenfold increase over last year
The Walgreens Flu Index indicates that flu activity this year is more than 10 times higher than in the previous year and has doubled over the past two weeks.
October 24, 2022
Page 2 of 32